Skip to main content
Aier Eye Hospital Group Co.,Ltd. logo

Aier Eye Hospital Group Co.,Ltd. — Investor Relations & Filings

Ticker · 300015 ISIN · CNE100000GR6 Shenzhen Stock Exchange Human health and social work activities
Filings indexed 2,708 across all filing types
Latest filing 2026-05-27 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 300015

About Aier Eye Hospital Group Co.,Ltd.

https://www.aierchina.com

Aier Eye Hospital Group Co., Ltd. is a global ophthalmic medical institution specializing in comprehensive eye care services. The group operates an extensive network of specialized hospitals providing clinical diagnosis, surgical intervention, and therapeutic treatments. Core medical services encompass refractive surgery, cataract treatment, glaucoma management, vitreoretinal disease care, and pediatric ophthalmology, with a significant focus on myopia prevention and control. The organization integrates clinical practice with academic research and professional education, maintaining a multi-tiered medical service system designed to improve accessibility to specialized eye care. Its service model emphasizes the application of advanced ophthalmic technologies and standardized clinical protocols across its international network of medical facilities.

Recent filings

Filing Released Lang Actions
关于向香港联交所递交境外上市外资股(H股)发行并上市的申请并刊发申请资料的公告
Share Issue/Capital Change Classification · 87% confidence The document is a corporate announcement that the company has submitted an application to the Hong Kong Stock Exchange for the issuance and listing of H‐shares and has published the related application materials. It contains no financial statements, no voting results, and is not a full report or certification. This fits the “Share Issue/Capital Change” category (announcements of new share issues).
2026-05-27 Chinese
关于补缴税款及调整2025年度企业所得税汇算清缴额的公告
Regulatory Filings Classification · 85% confidence The document is an official company announcement (公告) detailing supplemental tax payments and adjustments to the 2025 corporate income tax settlement amount, including amounts paid and accounting impact. It is not an annual or interim financial report, nor a transcript, dividend notice, or capital change announcement. It is a routine regulatory/compliance disclosure required by the exchange, fitting the “Regulatory Filings” category.
2026-05-20 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “2025年年度股东会决议公告” and provides detailed voting outcomes for each agenda item of the company’s 2025 Annual General Meeting, including vote counts and approval status for ordinary and special resolutions. This is clearly an official declaration of shareholder vote results, matching the Definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-18 Chinese
关于回购注销限制性股票减资暨通知债权人的公告
Transaction in Own Shares Classification · 88% confidence The document is an official corporate announcement by AIER Eye Hospital Group concerning the repurchase and cancellation of restricted stock (incentive plan shares) and the resulting reduction in registered capital, including notification to creditors. This is a buyback of the company’s own shares, which fits the definition of Transaction in Own Shares (Code: POS).
2026-05-18 Chinese
关于完成补选第七届董事会独立董事的公告
Board/Management Information Classification · 93% confidence The document is an official announcement regarding the completion of a by‐election for an independent director on the company’s seventh board, detailing the nomination, approval by the board and stock exchange, election at the shareholders’ meeting, change in board composition, and resignation of the previous independent director. This clearly falls under announcements of changes in the company’s board of directors. Hence, it should be classified under Board/Management Information (MANG).
2026-05-18 Chinese
湖南启元律师事务所关于爱尔眼科医院集团股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 85% confidence The document is a lawyer’s “法律意见书” (legal opinion letter) issued by Qiyuan Law Firm on the legality of Aier Eye Hospital Group’s 2025 annual shareholders’ meeting. It reviews meeting notice, quorum, voting procedures and detailed vote tallies, but is not itself a proxy solicitation, management presentation or standalone vote-results announcement by the company. There is no dedicated category for legal opinions, so it falls under miscellaneous regulatory/compliance filings. Thus, it is classified as a Regulatory Filing (RNS).
2026-05-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.